St. Louis, Missouri – April 03, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to Alexander Fleming Biomedical Sciences Research Center in Athens, Greece.


Researchers at the Center will use Partek GS to analyze microarray data from their studies in immunology, genetics, and molecular oncology. Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

Partek® Genomics SuiteTM (Partek GS)

St. Louis, Missouri – April 01, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to China Agricultural University.


Partek GS will be used to analyze genomic data generate from studies at the University. Founded in 1906, China Agricultural University is the top agricultural university in China.


Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

Partek® Genomics SuiteTM (Partek GS)

St. Louis, Missouri – April 01, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to Dana-Farber Cancer Institute, which is located in Boston.


Researchers at Dana-Farber will use Partek GS to analyze gene expression, SNP, and exon data. Because Partek GS can analyze data from different technologies and chip types, researchers there can use the same application for all their analysis needs. Dana-Farber Cancer Institute, founded in 1947, provides support, medicine, and research for many types of adult and pediatric cancers.


Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – April 01, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to Addenbrooke’s Hospital.


Research at Addenbrooke’s Hospital involves areas of cancer, diabetes, obesity, neuroscience, cardiovascular medicine, infection, immunity, genetics, and musculoskeletal disorders. Researchers there will use Partek GS to analyze genotyping data. Addenbrooke’s Hospital is located in Cambridge.


Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

Partek® Genomics SuiteTM (Partek GS)

St. Louis, Missouri – March 23, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to University of Rostock.


Partek GS will be used to analyze data from research studies at the University. Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

St. Louis, Missouri – March 20, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to Max Planck Institute for Terrestrial Microbiology.


Partek GS will be used to analyze large genomic data sets from research done at the Institute. Max Planck Institute for Terrestrial Microbiology is located in Germany.


Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats. Partek GS is part of the illumina•Connect software program and is Affymetrix GeneChip-compatible.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – March 19, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to Weill Medical College of Cornell University.


Weill Medical College of Cornell University has purchased Partek GS software to analyze genomic data. Scientists at the College are currently doing groundbreaking work in HIV research, vision research, cancer biology, and pharmacology. Weill Medical College was founded in 1898.


Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – March 17, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to University of Pennsylvania.


Partek GS will be used to analyze data from studies in the genetics of pediatric cancer. Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

St. Louis, Missouri – March 14, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to Stanford University.


Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

St. Louis, Missouri – March 12, 2008 – Partek Incorporated announced today that it has licensed Partek® Genomics SuiteTM (Partek GS) software to CRP-Santé (Public Research Center for Health).


CRP-Santé does research in many different areas including cancer, cardiology, virology, allergies, immunobiology, mental health, hereditary diseases, environmental health, toxicology, and neuro-oncology. Researchers at the facility will use Partek GS to analyze cancer genomics data. CRP-Santé is located in Luxembourg.


Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.


Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

Pages